Skip to content
10-K

Annual Report

Cell Source, Inc. CLCS

0001493152-24-024903

← back to feed
Filed
Jun 24, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jun 17, 2024 41.02M sh
Shares Diluted FY 2023 · Dec 31, 2022 34.84M sh
Operating Cash Flow FY 2023 · Dec 31, 2022 −$3.14M
Total Liabilities FY 2023 · Dec 31, 2022 $13.04M
Total Assets FY 2023 · Dec 31, 2022 $409.85K
Eps Diluted FY 2023 · Dec 31, 2022 −$0.18
Eps Basic FY 2023 · Dec 31, 2022 −$0.18
Net Income FY 2023 · Dec 31, 2022 −$5.17M
Operating Income FY 2023 · Dec 31, 2022 −$4.18M
Stockholders Equity FY 2023 · Dec 31, 2021 −$9.83M